For the SPARK NS 2024-2025 Parkinson’s Disease Translational Research Program (Program), SPARK NS will select and enroll a cohort of academic principal investigators (PIs) with therapeutic discoveries at any stage of development between target identification and entry into clinical trials. For selected projects, SPARK NS will provide funding, education, mentorship, and networking opportunities to support the translation of novel science to first-in-class therapeutics. The duration of the Program is 2 years. Projects selected will receive milestone-based support up to $2,000,000 during the 2-year program, including $50,000 of discretionary funding per year for the PIs of the selected projects.
For background information on the discovery and development of therapeutics, applicants are encouraged to consult A Practical Guide to Drug Development in Academia when drafting their proposals. A new edition of the book will be available in October 2023. Pre-order the book here.
Applicants should use the Microsoft Word Application Template for their proposals to ensure that their application meets the formatting requirements.